Emergency physician's dispatch by a paramedic-staffed emergency medical communication centre: sensitivity, specificity and search for a reference standard.


Journal

Scandinavian journal of trauma, resuscitation and emergency medicine
ISSN: 1757-7241
Titre abrégé: Scand J Trauma Resusc Emerg Med
Pays: England
ID NLM: 101477511

Informations de publication

Date de publication:
09 Feb 2021
Historique:
received: 28 07 2020
accepted: 29 01 2021
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 22 6 2021
Statut: epublish

Résumé

Some emergency medical systems (EMS) use a dispatch centre where nurses or paramedics assess emergency calls and dispatch ambulances. Paramedics may also provide the first tier of care "in the field", with the second tier being an Emergency Physician (EP). In these systems, the appropriateness of the decision to dispatch an EP to the first line at the same time as the ambulance has not often been measured. The main objective of this study was to compare dispatching an EP as part of the first line emergency service with the severity of the patient's condition. The secondary objective was to highlight the need for a recognized reference standard to compare performance analyses across EMS. This prospective observational study included all emergency calls received in Geneva's dispatch centre between January 1st, 2016 and June 30th, 2019. Emergency medical dispatchers (EMD) assigned a level of risk to patients at the time of the initial call. Only the highest level of risk led to the dispatch of an EP. The severity of the patient's condition observed in the field was measured using the National Advisory Committee for Aeronautics (NACA) scale. Two reference standards were proposed by dichotomizing the NACA scale. The first compared NACA≥4 with other conditions and the second compared NACA≥5 with other conditions. The level of risk identified during the initial call was then compared to the dichotomized NACA scales. 97'861 assessments were included. Overall prevalence of sending an EP as first line was 13.11, 95% CI [12.90-13.32], and second line was 2.94, 95% CI [2.84-3.05]. Including NACA≥4, prevalence was 21.41, 95% CI [21.15-21.67], sensitivity was 36.2, 95% CI [35.5-36.9] and specificity 93.2 95% CI [93-93.4]. The Area Under the Receiver-Operating Characteristics curve (AUROC) of 0.7507, 95% CI [0.74734-0.75397] was acceptable. Looking NACA≥5, prevalence was 3.09, 95% CI [2.98-3.20], sensitivity was 64.4, 95% CI [62.7-66.1] and specificity 88.5, 95% CI [88.3-88.7]. We found an excellent AUROC of 0.8229, 95% CI [0.81623-0.82950]. The assessment by Geneva's EMD has good specificity but low sensitivity for sending EPs. The dichotomy between immediate life-threatening and other emergencies could be a valid reference standard for future studies to measure the EP's dispatching performance.

Sections du résumé

BACKGROUND BACKGROUND
Some emergency medical systems (EMS) use a dispatch centre where nurses or paramedics assess emergency calls and dispatch ambulances. Paramedics may also provide the first tier of care "in the field", with the second tier being an Emergency Physician (EP). In these systems, the appropriateness of the decision to dispatch an EP to the first line at the same time as the ambulance has not often been measured. The main objective of this study was to compare dispatching an EP as part of the first line emergency service with the severity of the patient's condition. The secondary objective was to highlight the need for a recognized reference standard to compare performance analyses across EMS.
METHODS METHODS
This prospective observational study included all emergency calls received in Geneva's dispatch centre between January 1st, 2016 and June 30th, 2019. Emergency medical dispatchers (EMD) assigned a level of risk to patients at the time of the initial call. Only the highest level of risk led to the dispatch of an EP. The severity of the patient's condition observed in the field was measured using the National Advisory Committee for Aeronautics (NACA) scale. Two reference standards were proposed by dichotomizing the NACA scale. The first compared NACA≥4 with other conditions and the second compared NACA≥5 with other conditions. The level of risk identified during the initial call was then compared to the dichotomized NACA scales.
RESULTS RESULTS
97'861 assessments were included. Overall prevalence of sending an EP as first line was 13.11, 95% CI [12.90-13.32], and second line was 2.94, 95% CI [2.84-3.05]. Including NACA≥4, prevalence was 21.41, 95% CI [21.15-21.67], sensitivity was 36.2, 95% CI [35.5-36.9] and specificity 93.2 95% CI [93-93.4]. The Area Under the Receiver-Operating Characteristics curve (AUROC) of 0.7507, 95% CI [0.74734-0.75397] was acceptable. Looking NACA≥5, prevalence was 3.09, 95% CI [2.98-3.20], sensitivity was 64.4, 95% CI [62.7-66.1] and specificity 88.5, 95% CI [88.3-88.7]. We found an excellent AUROC of 0.8229, 95% CI [0.81623-0.82950].
CONCLUSION CONCLUSIONS
The assessment by Geneva's EMD has good specificity but low sensitivity for sending EPs. The dichotomy between immediate life-threatening and other emergencies could be a valid reference standard for future studies to measure the EP's dispatching performance.

Identifiants

pubmed: 33563301
doi: 10.1186/s13049-021-00844-y
pii: 10.1186/s13049-021-00844-y
pmc: PMC7871575
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Références

Acta Anaesthesiol Scand. 2017 May;61(5):557-565
pubmed: 28317095
Cardiol Clin. 2018 Aug;36(3):343-350
pubmed: 30293600
Scand J Trauma Resusc Emerg Med. 2018 Nov 9;26(1):94
pubmed: 30413213
J Trauma Acute Care Surg. 2019 Oct;87(4):978-989
pubmed: 31335754
J Trauma Acute Care Surg. 2012 Sep;73(3):709-15
pubmed: 22929499
Crit Care. 2016 Jan 09;20:4
pubmed: 26747085
Scand J Trauma Resusc Emerg Med. 2009 Mar 05;17:12
pubmed: 19265550
Emerg Med Australas. 2016 Dec;28(6):716-724
pubmed: 27592247
Injury. 2015 Jul;46(7):1281-6
pubmed: 25907401
Scand J Trauma Resusc Emerg Med. 2010 Feb 18;18:9
pubmed: 20167060
Singapore Med J. 2017 Jul;58(7):449-452
pubmed: 28741009
Scand J Trauma Resusc Emerg Med. 2019 Nov 7;27(1):102
pubmed: 31699120
J Thorac Oncol. 2010 Sep;5(9):1315-6
pubmed: 20736804
Am J Emerg Med. 2020 Nov;38(11):2249-2253
pubmed: 31924440
Resuscitation. 2018 May;126:80-82
pubmed: 29471008
Emerg Med J. 2009 Feb;26(2):128-34
pubmed: 19164630
PLoS One. 2018 Sep 24;13(9):e0204169
pubmed: 30248116
Scand J Trauma Resusc Emerg Med. 2017 Apr 13;25(1):40
pubmed: 28407809
Resuscitation. 1995 Oct;30(2):133-40
pubmed: 8560102
BMC Emerg Med. 2010 Mar 08;10:6
pubmed: 20211021
Anaesthesist. 2001 Mar;50(3):150-4
pubmed: 11315486
BMC Emerg Med. 2015 Oct 27;15:32
pubmed: 26507648
Prehosp Disaster Med. 2013 Oct;28(5):523-8
pubmed: 23947338
Eur J Emerg Med. 2019 Oct;26(5):366-372
pubmed: 30308574
Cochrane Database Syst Rev. 2015 Dec 15;(12):CD009228
pubmed: 26671262
Anaesthesist. 2019 May;68(5):282-293
pubmed: 30899970
Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Oct;38(10):630-42
pubmed: 14508702
BMJ Open. 2016 Nov 14;6(11):e012799
pubmed: 28137831

Auteurs

Victor Nathan Chappuis (VN)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland.

Hélène Deham (H)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland.

Philippe Cottet (P)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland.

Birgit Andrea Gartner (BA)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland.

François Pierre Sarasin (FP)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland.

Marc Niquille (M)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland.

Laurent Suppan (L)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland.

Robert Larribau (R)

Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, CH 1211, Geneva, Switzerland. Robert.larribau@hcuge.ch.
Division of Emergency Medicine, Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospital, Chemin du Petit-Bel-Air 2, CH 1226, Geneva, Thônex, Switzerland. Robert.larribau@hcuge.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH